PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
METCB vs. ALT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between METCB and ALT is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

METCB vs. ALT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
-4.07%
98.32%
METCB
ALT

Key characteristics

Sharpe Ratio

METCB:

-0.52

ALT:

0.03

Sortino Ratio

METCB:

-0.52

ALT:

0.84

Omega Ratio

METCB:

0.94

ALT:

1.10

Calmar Ratio

METCB:

-0.58

ALT:

0.03

Martin Ratio

METCB:

-1.31

ALT:

0.08

Ulcer Index

METCB:

16.65%

ALT:

42.49%

Daily Std Dev

METCB:

42.03%

ALT:

99.52%

Max Drawdown

METCB:

-37.59%

ALT:

-99.94%

Current Drawdown

METCB:

-37.16%

ALT:

-99.70%

Fundamentals

Market Cap

METCB:

$595.54M

ALT:

$640.12M

EPS

METCB:

$0.67

ALT:

-$1.57

Total Revenue (TTM)

METCB:

$698.13M

ALT:

$52.00K

Gross Profit (TTM)

METCB:

$127.11M

ALT:

-$2.01M

EBITDA (TTM)

METCB:

$118.58M

ALT:

-$101.42M

Returns By Period

In the year-to-date period, METCB achieves a -23.14% return, which is significantly higher than ALT's -26.67% return.


METCB

YTD

-23.14%

1M

-6.47%

6M

-7.57%

1Y

-22.85%

5Y*

N/A

10Y*

N/A

ALT

YTD

-26.67%

1M

2.48%

6M

28.71%

1Y

4.56%

5Y*

36.27%

10Y*

-34.02%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

METCB vs. ALT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ramaco Resources Inc. (METCB) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for METCB, currently valued at -0.52, compared to the broader market-4.00-2.000.002.00-0.520.03
The chart of Sortino ratio for METCB, currently valued at -0.52, compared to the broader market-4.00-2.000.002.004.00-0.520.84
The chart of Omega ratio for METCB, currently valued at 0.94, compared to the broader market0.501.001.502.000.941.10
The chart of Calmar ratio for METCB, currently valued at -0.58, compared to the broader market0.002.004.006.00-0.580.06
The chart of Martin ratio for METCB, currently valued at -1.31, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.310.08
METCB
ALT

The current METCB Sharpe Ratio is -0.52, which is lower than the ALT Sharpe Ratio of 0.03. The chart below compares the historical Sharpe Ratios of METCB and ALT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.52
0.03
METCB
ALT

Dividends

METCB vs. ALT - Dividend Comparison

METCB's dividend yield for the trailing twelve months is around 7.45%, while ALT has not paid dividends to shareholders.


TTM2023202220212020201920182017
METCB
Ramaco Resources Inc.
7.45%3.14%0.00%0.00%0.00%0.00%0.00%0.00%
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.87%

Drawdowns

METCB vs. ALT - Drawdown Comparison

The maximum METCB drawdown since its inception was -37.59%, smaller than the maximum ALT drawdown of -99.94%. Use the drawdown chart below to compare losses from any high point for METCB and ALT. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%JulyAugustSeptemberOctoberNovemberDecember
-37.16%
-40.26%
METCB
ALT

Volatility

METCB vs. ALT - Volatility Comparison

The current volatility for Ramaco Resources Inc. (METCB) is 17.80%, while Altimmune, Inc. (ALT) has a volatility of 21.94%. This indicates that METCB experiences smaller price fluctuations and is considered to be less risky than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
17.80%
21.94%
METCB
ALT

Financials

METCB vs. ALT - Financials Comparison

This section allows you to compare key financial metrics between Ramaco Resources Inc. and Altimmune, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab